Traditionally, front-line chemotherapy for pancreatic cancer involves gemcitabine. Then, FOLFIRINOX, a combination therapy involving four different drugs, becomes the standard of care. It is also ...
Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, ...